AndreaBozzo/ceres-open-data-index huggingface dataset:
Patent AT-E401823-T1: [Translated] METHOD AND DEVICE FOR DETERMINING A LIGHT TRANSPORT PARAMETER AND AN ANALYTE IN A BIOLOGICAL MATRIX

A method for the selective determination of the scattering index mu<SUB>s </SUB>of a scattering biological matrix, in particular for the purpose of non-invasive determination of the concentration of glucose in the skin, by means of detection measurements, in each of which light in the form of primary light ( 9 ) is irradiated into the biological matrix ( 5 ) and an intensity measurement value of secondary light ( 12 ) exiting at a detection site ( 33 - 40 ) that is located at different measuring distances (rho) from the respective light irradiation site ( 10 ) during the detection measurements is measured. In order to improve the quality and selectivity of the determination of mu<SUB>s</SUB>, the primary light is irradiated obliquely at an angle between 5° and 85° using a contacting light-guiding element. In at least two detection measurements, the measuring distance (rho) between the respective light irradiation site ( 10 ) and the respective detection site ( 33 - 40 ) corresponds to no more than five times the mean free path length of the light propagating in the biological matrix.
Patent AT-E401686-T1: [Translated] STRUCTURED CABLING SYSTEM AND METHOD

A structured cabling system comprises a plurality of data cables (6A-6F), one end of each cable being secured to a jack of a multiple jack assembly (1) and the other end of each cable being secured to an individual jack (9A-9F) located within a protective enclosure (11). The individual cables are mechanically secured to at least the protective enclosure (11) and/or a strain relief member (8) within the cable bundle is secured to the protective enclosure (11). The entire assembly may be pre-formed under factory conditions and delivered to an installation site. The multiple jack assembly (1) may then be secured, preferably by snap-fitting, to a rack assembly and the protective enclosure (10) may be used to draw the entire cable length to the required position. Once the cable is in position the protective enclosure (10) is discarded and the jack secured to their final use positions. In an alternative embodiment the protective enclosure forms a housing for the jacks (9A-9F) in their final use position and may, for example, be snap-fitted to a floor box for this purpose.
Publications Using SAMHSA DataTrend Tables (Prevalence Estimates) - 7.1 to 7.45

These detailed tables show trends in population totals and prevalence estimates of illicit drug use, risk and protective factors, substance initiation, substance dependence/abuse, and need/receipt of substance use treatment from the 2012 National Survey on Drug Use and Health (NSDUH). Substances examined include illicit drugs (e.g., marijuana, cocaine, heroin, hallucinogens (including LSD, PCP, Ecstasy, Ketamine, DMT/AMT/Foxy, Salvia divinorum), inhalants, and the nonmedical use of prescription-type pain relievers (including OxyContin), tranquilizers, stimulants (Adderall) , sedatives (GHB, Ambien), non-prescription cold medicine, alcohol, and tobacco products (including cigarettes, smokeless tobacco, cigars, pipes). Results are provided for lifetime, past year, and past month use by age group, gender, race/ethnicity, education level, employment status, and geographic area. Comparisons are made between 2012 and 2002 through 2011.
COVID-19 Hospital Data from the National Hospital Care Survey

The National Hospital Care Survey (NHCS) collects data on patient care in hospital-based settings to describe patterns of health care delivery and utilization in the United States. Settings currently include inpatient and emergency departments (ED). Additionally, the NHCS contributes data that may inform public health emergencies as the survey is designed to capture emerging diseases and viruses that require hospitalizations, including COVID-19 encounters. The 2020 - 2023 NHCS are not yet fully operational so it is important to note that these data are not nationally representative.

The data are from 26 hospitals submitting inpatient and 26 hospitals submitting ED Uniform Bill (UB)-04 administrative claims from March 18, 2020-December 26, 2023.  Even though the data are not nationally representative, they can provide insight on the impact of COVID-19 on various types of hospitals throughout the country. This information is not available in other hospital reporting systems. The NHCS data from these hospitals can show results by a combination of indicators related to COVID-19, such as length of inpatient stay, in-hospital mortality, comorbidities, and intubation or ventilator use. NHCS data allow for reporting on patient conditions and treatments within the hospital over time.
Renewed Form for Title IV-E Programs Quarterly Financial Report

This Program Instruction (PI) provides State, Territorial, and Tribal title IV-E agencies with the renewed form and instructions approved by the U.S. Office of Management and Budget (OMB) for reporting quarterly financial information on the title IV-E Foster Care, Adoption Assistance, Guardianship Assistance, Kinship Navigator and Prevention Services Programs, as well as annual reporting data for Adoption Savings.

An updated version of the CB-496 form was released with ACF-ACYF-CB-PI-24-09.

Metadata-only record linking to the original dataset. Open original dataset below.
Patent AT-E40023-T1: [Translated] DEVICE WITH A HALL ELEMENT INTEGRATEABLE IN AN INTEGRATED CIRCUIT.

A Hall element incorporated inside a semiconductor body has a P-N junction barrier which surrounds the active zone of the Hall element in all directions. The output of the Hall element is connected through a feedback control circuit to control the thickness of the P-N junction barrier, thereby ensuring long duration, temperture stability and linearity for the Hall element.
Polyethylene glycol 3350, sodium sulfate, sodium chloride, potassium chloride, ascorbic acid, sodium ascorbate

PLENVU is a prescription bowel cleansing kit used to prepare the colon for procedures like colonoscopy. It contains polyethylene glycol 3350, sodium sulfate, and other electrolytes in powder form to mix with water for oral solution. Manufactured by Salix Pharmaceuticals, Inc. This information was generated using AI and is provided for informational and research purposes only.
Compound 529340: 5-Methyl-1-propylimidazole

Chemical compound data from PubChem database. IUPAC Name: 5-methyl-1-propylimidazole. Molecular Formula: C7H12N2. Molecular Weight: 124.18. This dataset contains comprehensive chemical information including structural data, physical properties, and biological activities. Useful for drug discovery, chemical research, and educational purposes.
Compound 528693: 1-Butyl-3,5-dimethylbenzene

Chemical compound data from PubChem database. IUPAC Name: 1-butyl-3,5-dimethylbenzene. Molecular Formula: C12H18. Molecular Weight: 162.27. This dataset contains comprehensive chemical information including structural data, physical properties, and biological activities. Useful for drug discovery, chemical research, and educational purposes.
Compound 530280: Lupulone, TMS

Chemical compound data from PubChem database. IUPAC Name: 4-(3-methylbutanoyl)-2,6,6-tris(3-methylbut-2-enyl)-3,5-bis(trimethylsilyloxy)cyclohexa-2,4-dien-1-one. Molecular Formula: C32H54O4Si2. Molecular Weight: 558.9. This dataset contains comprehensive chemical information including structural data, physical properties, and biological activities. Useful for drug discovery, chemical research, and educational purposes.
Compound 525993: N1N1-dimethyl-N2-ortho-nitrophenylformamidine

Chemical compound data from PubChem database. IUPAC Name: N,N-dimethyl-N'-(2-nitrophenyl)methanimidamide. Molecular Formula: C9H11N3O2. Molecular Weight: 193.2. This dataset contains comprehensive chemical information including structural data, physical properties, and biological activities. Useful for drug discovery, chemical research, and educational purposes.
Comparison of 2002-2003 and 2009-2010 prevalence estimates for persons aged 12 or older, 12 to 17, 18 to 25, and 26 or older; also for persons 12 to 20 for two alcohol measures.

This report presents trends of estimates for measures of substance use and mental health based on the combined 2002 and 2003 and the combined 2009 and 2010 National Surveys on Drug Use and Health (NSDUHs). Topics covered include past month substance use (e.g., illicit drugs, marijuana, cocaine, pain relievers, alcohol, tobacco), substance dependence, abuse, and treatment need, past year serious mental illness (SMI), any mental illness (AMI), suicidal thoughts, and major depressive episode (MDE). Resuts are provided for five age groups: 12 to 17, 18 to 25, 26 or older, 18 or older and all persons 12 or older.
Recovery Services Provided by Substance Abuse Treatment Facilities in the United States

This is a National Survey of Substance Abuse Treatment Services (N-SSATS)  short report showing types of recovery services provided by substance abuse treatment facilities in the United States in 2012. The National Survey of Substance Abuse Treatment Services (N-SSATS) is an annual survey designed to collect information from all facilities in the United States, both public and private, that provide substance abuse treatment.
Joint effects of citrus peel use and black tea intake on the risk of squamous cell carcinoma of the skin

Background
          Differences in tea drinking habits and/or citrus peel use are likely to vary by populations and could contribute to the inconsistencies found between studies comparing their consumption and cancer risk.
        
        
          Methods
          A population-based case-control study was used to evaluate the relationships between citrus peel use and black tea intake and squamous cell carcinoma (SCC) of the skin. Moreover, we assessed the independent and interactive effects of citrus peel and black tea in the development of SCC.
        
        
          Results
          Hot and iced teas were consumed by 30.7% and 51.8% of the subjects, respectively. Peel consumption was reported by 34.5% of subjects. Controls were more likely than were cases to report citrus peel use (odds ratio (OR) = 0.67) and hot tea intake (OR = 0.79). After adjustment for hot and iced tea intake, the ORs associated with citrus peel use were 0.55 and 0.69, respectively, whereas the corresponding adjusted ORs for hot and iced tea intake after adjustment for citrus peel use were 0.87 and 1.22 respectively. Compared with those who did not consume hot black tea or citrus peel, the adjusted ORs associated with sole consumption of hot black tea or citrus peel were 0.60 and 0.30, respectively. Subjects who reported consumption of both hot black tea and citrus peel had a significant marked decrease (OR= 0.22; 95% CI = 0.10 – 0.51) risk of skin SCC.
        
        
          Conclusion
          These results indicate that both citrus peel use and strong (hot) black tea have independent potential protective effects in relation to skin SCC.
2010 State Profile — South Carolina

This state profile includes data from facilities in South Carolina that reported to N-SSATS for the survey reference date March 31, 2010. Data were collected on the location, characteristics, services offered, and number of clients in treatment at alcohol and drug abuse treatment facilities (both public and private) in South Carolina. In South Carolina, 103 substance abuse treatment facilities were included in the 2010 N-SSATS, reporting that there were 14,490 clients in substance abuse treatment on March 31, 2010. The survey response rate in South Carolina was 87.3%.
Table 21. Dependence or Abuse of Illicit Drugs or Alcohol in the Past Year among Persons Aged 12 or Older, by State and Substate Regions: Percentages, Annual Averages Based on 2010, 2011, and 2012 NSDUHs

Table 21. Dependence or Abuse of Illicit Drugs or Alcohol in the Past Year among Persons Aged 12 or Older, by State and Substate Regions: Percentages, Annual Averages Based on 2010, 2011, and 2012 NSDUHs
2011 CMHS Uniform Reporting System (URS) Output Tables for Republic of Palau

Center for Mental Health Services (CMHS) Uniform Reporting System (URS) Output Tables for 2011. The Uniform Reporting System (URS) is a state and national reporting system collected annually to support the Community Mental Health Services Block Grant program. State Mental Health Authorities report on National Outcome Measures (NOMS), evidence based practices, and utilization measures providing an overview of state mental health delivery systems.
Abbott Infant Formula Recall

This list includes products subject to recall since September 2010 related to infant formula distributed by Abbott. This list will be updated with publicly available information as received. The information is current as of the date indicated. If we learn that any information is not accurate, we will revise the list as soon as possible. When available, this database also includes photos of recalled products that have been voluntarily submitted by recalling firms to the FDA to assist the public in identifying those products that are subject to recall.
Compound 528423: Dihydrochalcone, 2',6'-dihydroxy-4'-methoxy, bis-TMS

Chemical compound data from PubChem database. IUPAC Name: 3-[4-methoxy-2,6-bis(trimethylsilyloxy)phenyl]-1-phenylpropan-1-one. Molecular Formula: C22H32O4Si2. Molecular Weight: 416.7. This dataset contains comprehensive chemical information including structural data, physical properties, and biological activities. Useful for drug discovery, chemical research, and educational purposes.
Gastric adenocarcinoma in a patient re-infected with

Background
          Helicobacter pylori (H. pylori) has been etiologically linked with primary gastric lymphoma (PGL) and gastric carcinoma (GC). There are a few reports of occurrence of both diseases in the same patient with H. pylori infection.
        
        
          Case presentation
          We report a patient with PGL in whom the tumor regressed after surgical resection combined with eradication of H. pylori infection. However, he developed GC on follow up; this was temporally associated with recrudescence / re-infection of H. pylori. This is perhaps first report of such occurrence.
        
        
          Conclusions
          Possible cause and effect relationship between H. pylori infection and both PGL and GC is discussed. This case also documents a unique problem in management of PGL in tropical countries where re-infection with H. pylori is supposed to be high.
2012 Uniform Reporting System (URS) Tables for Vermont

Center for Mental Health Services (CMHS) Uniform Reporting System (URS) Output Tables for 2012. The Uniform Reporting System (URS) is a state and national reporting system collected annually to support the Community Mental Health Services Block Grant program. State Mental Health Authorities report on National Outcome Measures (NOMS), evidence based practices, and utilization measures providing an overview of state mental health delivery systems.
NNDSS - Table II. West Nile virus disease

NNDSS - Table II. West Nile virus disease - 2015.In this Table, provisional cases of selected notifiable diseases (≥1,000 cases reported during the preceding year), and selected low frequency diseases are displayed.The Table includes total number of cases reported in the United States, by region and by states, in accordance with the current method of displaying MMWR data.  Data on United States exclude counts from US territories. Note:These are provisional cases of selected national notifiable diseases, from the National Notifiable Diseases Surveillance System (NNDSS). NNDSS data reported by the 50 states, New York City, the District of Columbia, and the U.S. territories are collated and published weekly as numbered tables printed in the back of the Morbidity and Mortality Weekly Report (MMWR). Cases reported by state health departments to CDC for weekly publication are provisional because of ongoing revision of information and delayed reporting. Case counts in this table are presented as they were published in the MMWR issues. Therefore, numbers listed in later MMWR weeks may reflect changes made to these counts as additional information becomes available. Footnotes:C.N.M.I.: Commonwealth of Northern Mariana Islands. U: Unavailable.    -: No reported cases.    N: Not reportable.    NN: Not Nationally Notifiable.    NP: Nationally notifiable but not published.    Cum: Cumulative year-to-date counts.    Med: Median.    Max: Maximum. * Three low incidence conditions, rubella, rubella congenital, and tetanus, have been moved to Table 2 to facilitate case count verification with reporting jurisdictions. ��� Case counts for reporting year 2015 are provisional and subject to change. For further information on interpretation of these data, see http://wwwn.cdc.gov/nndss/document/ProvisionalNationaNotifiableDiseasesSurveillanceData20100927.pdf. Data for TB are displayed in Table IV, which appears quarterly. �� Updated weekly from reports to the Division of Vector-Borne Diseases, National Center for Emerging and Zoonotic Infectious Diseases (ArboNET Surveillance). Data for California serogroup, Chikungunya virus, eastern equine, Powassan, St. Louis, and western equine diseases are available in Table I. �� Not reportable in all states. Data from states where the condition is not reportable are excluded from this table, except starting in 2007 for the domestic arboviral diseases, influenza-associated pediatric mortality, and in 2003 for SARS-CoV. Reporting exceptions are available at http://wwwn.cdc.gov/nndss/downloads.html.
Patent AT-E401543-T1: [Translated] COOLED ROLLER FOR HANDLING STEEL PRODUCTS

The invention concerns a roller (R), used in continuous product heating furnaces for handling and conveying steel products and in particular slabs. The associated apparatus includes a cooled central shaft (1), cooled by a liquid. On the shaft are mounted a plurality of discs (2), for supporting the products (3) to be transported, arranged perpendicularly to the longitudinal geometrical axis of the roller (R), spaced apart along the axis of the roller (R) and separated by an insulating sleeve (4). The insulating sleeve (4) is maintained at each longitudinal end by at least one cold component (5) secured to the shaft (1) and cooled by the shaft, with axial play (Ja) between the sleeve (4) and the shaft (1) such that possible sagging of the shaft (1) may occur in use without causing substantial mechanical stress on the insulating sleeve (4) and the heat transferred from the sleeve (4) to the shaft (1), and from the discs (2) to the sleeve (4) is limited.
Compound 527238: 6-Methyl-10-methylidene-3-propan-2-ylidenespiro[4.5]dec-8-ene

Chemical compound data from PubChem database. IUPAC Name: 6-methyl-10-methylidene-3-propan-2-ylidenespiro[4.5]dec-8-ene. Molecular Formula: C15H22. Molecular Weight: 202.33. This dataset contains comprehensive chemical information including structural data, physical properties, and biological activities. Useful for drug discovery, chemical research, and educational purposes.
2014 CMHS Uniform Reporting System (URS) Table for District of Columbia

2014 Center for Mental Health Services (CMHS) Uniform Reporting System (URS) Output Tables for the District of Columbia. The URS state reporting system is collected annually to support the Community Mental Health Services Block Grant program. State Mental Health Authorities report on National Outcome Measures (NOMS), evidence based practices, and utilization measures providing an overview of state mental health delivery systems.
Compound 530071: 1-Methylheptyl 5-bromopentanoate

Chemical compound data from PubChem database. IUPAC Name: trimethylsilyl 2-oxoacetate. Molecular Formula: C5H10O3Si. Molecular Weight: 146.22. This dataset contains comprehensive chemical information including structural data, physical properties, and biological activities. Useful for drug discovery, chemical research, and educational purposes.
Patent AT-E400653-T1: [Translated] CHIMERIC RECEPTORS AND METHOD FOR IDENTIFYING COMPOUNDS HAVING ACTIVITY AS METABOTROPIC GLUTAMA RECEPTORS AND USE OF SUCH COMPOUNDS IN THE TREATMENT OF NEUROLOGICAL DISEASES AND NEUROLOGICAL DISORDERS

The present invention provides chimeric receptors. The chimeric receptors comprise at least one region homologous to a region of a metabotropic glutamate receptor and at least one region homologous to a region of a calcium receptor. The invention also includes methods of preparing such chimeric receptors, and methods of using such receptors to identify and characterize compounds which modulate the activity of metabotropic glutamate receptors or calcium receptors. The invention also relates to compounds and methods for modulating metabotropic glutamate receptor activity and binding to metabotropic glutamate receptors. Modulation of metabotropic glutamate receptor activity can be used for different purposes such as treating neurological disorders and diseases, inducing an analgesic effect, cognition enhancement, and inducing a muscle-relaxant effect.
Patent AT-E399716-T1: [Translated] DEVICE FOR FILLING A BAG

The filling device includes an issuing funnel (12), filling tube (13), a conveyor screw (14) in the filling tube and connected to a rotary drive motor, and a height adjustable closer (16) at the lower end of the filling tube. The rotary drive motor, conveyor screw and closer are an adjustable in height relative to the filling tube.
Wisconsin (WI)

This report uses 2008 to 2010 National Survey on Drug Use and Health (NSDUH) to assess past year alcohol use disorder and illicit drug use disorder among persons aged 12 or older for Wisconsin overall and for substate regions within Wisconsin. Topics covered include past month substance use (e.g., illicit drugs, marijuana, cocaine, pain relievers, alcohol, tobacco), substance dependence, abuse, and treatment need, past year serious mental illness (SMI), any mental illness (AMI), suicidal thoughts, and major depressive episode (MDE).